• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Propanc Biopharma, Inc. - Common Stock (NQ:PPCB)

    0.3610 -0.0629 (-14.84%)
    Streaming Delayed Price Updated: 1:07 PM EST, Jan 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 163,720
    Open 0.4380
    Bid (Size) 0.3612 (100)
    Ask (Size) 0.3700 (1,000)
    Prev. Close 0.4239
    Today's Range 0.3610 - 0.4380
    52wk Range 0.4200 - 1.980
    Shares Outstanding 13,364,244
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
    The Science, Clinical Promise, & Market Outlook 
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Propanc Biopharma Provides Shareholder Update
    CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026 
    From Propanc Biopharma, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -36.9%
    -36.9%
    1 Month
    -51.9%
    -51.9%
    3 Month
    -79.1%
    -79.1%
    6 Month
    -79.6%
    -79.6%
    1 Year
    -79.6%
    -79.6%

    More News

    Read More
    News headline image
    Propanc Biopharma Investigates “Mesenchymal Drift” to Reverse Chronic Diseases Defined by Altos Labs
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company’s R&D Pipeline
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
    From Propanc Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy
    From Propanc Biopharma, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Propanc Biopharma, Inc. - Common Stock publicly traded?
    Yes, Propanc Biopharma, Inc. - Common Stock is publicly traded.
    What exchange does Propanc Biopharma, Inc. - Common Stock trade on?
    Propanc Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Propanc Biopharma, Inc. - Common Stock?
    The ticker symbol for Propanc Biopharma, Inc. - Common Stock is PPCB on the Nasdaq Stock Market
    What is the current price of Propanc Biopharma, Inc. - Common Stock?
    The current price of Propanc Biopharma, Inc. - Common Stock is 0.3610
    When was Propanc Biopharma, Inc. - Common Stock last traded?
    The last trade of Propanc Biopharma, Inc. - Common Stock was at 01/15/26 01:07 PM ET
    What is the market capitalization of Propanc Biopharma, Inc. - Common Stock?
    The market capitalization of Propanc Biopharma, Inc. - Common Stock is 4.82M
    How many shares of Propanc Biopharma, Inc. - Common Stock are outstanding?
    Propanc Biopharma, Inc. - Common Stock has 5M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.